Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,340

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies

Open access
Williamson, Gary, Manach, Claudine·2005·The American Journal of Clinical Nutrition

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ajcn/81.1.243s

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 113

  1. Rowland, 2003, Bioavailability of phyto-oestrogens, Br J Nutr, 89, 838
  2. Day, 2001, Biomarkers for exposure to dietary flavonoids: a review of the current evidence for identification of quercetin glycosides in plasma, Br J Nutr, 86, S105, 10.1079/BJN2001342 · DOI
  3. Hollman, 1997, Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man, FEBS Lett, 418, 152, 10.1016/S0014-5793(97)01367-7 · DOI · Paper page
  4. Donovan, 1999, Catechin is present as metabolites in human plasma after consumption of red wine, J Nutr, 129, 1662, 10.1093/jn/129.9.1662 · DOI · Paper page
  5. Setchell, 2001, Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements, J Nutr, 131, 1362S, 10.1093/jn/131.4.1362S · DOI · Paper page
  6. Williamson, 2003, The use of flavonoid aglycones in in vitro systems to test biological activities: based on bioavailability data, is this a valid approach?, Phytochem Rev, 1, 215, 10.1023/A:1022515602191 · DOI
  7. Kudolo, 2000, The effect of 3-month ingestion of Ginkgo biloba extract on pancreatic β-cell function in response to glucose loading in normal glucose-tolerant individuals, J Clin Pharmacol, 40, 647, 10.1002/j.1552-4604.2000.tb05991.x · DOI
  8. Kudolo, 2001, The effect of 3-month ingestion of Ginkgo biloba extract (EGb 761) on pancreatic β-cell function in response to glucose loading in individuals with non–insulin-dependent diabetes mellitus, J Clin Pharmacol, 41, 600, 10.1177/00912700122010483 · DOI
  9. Roncin, 1996, EGb 761 in control of acute mountain sickness and vascular reactivity to cold exposure, Aviat Space Environ Med, 67, 445
  10. Pietri, 1997, Ginkgo biloba extract (EGb 761) pretreatment limits free radical-induced oxidative stress in patients undergoing coronary bypass surgery, Cardiovasc Drugs Ther, 11, 121, 10.1023/A:1007728729844 · DOI
  11. Allain, 1993, Effect of two doses of Ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects, Clin Ther, 15, 549
  12. Kim, 2003, Effects of phenol-depleted and phenol-rich diets on blood markers of oxidative stress, and urinary excretion of quercetin and kaempferol in healthy volunteers, J Am Coll Nutr, 22, 217, 10.1080/07315724.2003.10719296 · DOI
  13. Boyle, 2000, Absorption and DNA protective effects of flavonoid glycosides from an onion meal, Eur J Nutr, 39, 213, 10.1007/s003940070014 · DOI · Paper page
  14. McAnlis, 1999, Absorption and antioxidant effects of quercetin from onions, in man, Eur J Clin Nutr, 53, 92, 10.1038/sj.ejcn.1600682 · DOI
  15. Conquer, 1998, Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects, J Nutr, 128, 593, 10.1093/jn/128.3.593 · DOI · Paper page
  16. Janssen, 1998, Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study, Am J Clin Nutr, 67, 255, 10.1093/ajcn/67.2.255 · DOI · Paper page
  17. Lean, 1999, Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA, Diabetes, 48, 176, 10.2337/diabetes.48.1.176 · DOI
  18. Morrow, 2001, Dietary supplementation with the anti-tumour promoter quercetin: its effects on matrix metalloproteinase gene regulation, Mutat Res, 480–481, 269, 10.1016/S0027-5107(01)00184-1 · DOI
  19. Shoskes, 2003, Phase I study of oral bioflavonoids in cadaveric renal transplant recipients: effects on delayed graft function and calcineurin inhibitor toxicities, Transplant Proc, 35, 841, 10.1016/S0041-1345(02)04038-1 · doi:10.1016/s0041-1345(02)04038-1
  20. Shoskes, 1999, Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial, Urology, 54, 960, 10.1016/S0090-4295(99)00358-1 · DOI · Paper page
  21. Chopra, 2000, Nonalcoholic red wine extract and quercetin inhibit LDL oxidation without affecting plasma antioxidant vitamin and carotenoid concentrations, Clin Chem, 46, 1162, 10.1093/clinchem/46.8.1162 · DOI
  22. Katske, 2001, Treatment of interstitial cystitis with a quercetin supplement, Tech Urol, 7, 44
  23. Cassidy, 1995, Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products, Br J Nutr, 74, 587, 10.1079/BJN19950160 · DOI · Paper page
  24. Yamori, 2002, Soybean isoflavones reduce postmenopausal bone resorption in female Japanese immigrants in Brazil: a ten-week study, J Am Coll Nutr, 21, 560, 10.1080/07315724.2002.10719255 · DOI
  25. Jenkins, 2002, Effects of high- and low-isoflavone (phytoestrogen) soy foods on inflammatory biomarkers and proinflammatory cytokines in middle-aged men and women, Metabolism, 51, 919, 10.1053/meta.2002.33352 · DOI
  26. Morabito, 2002, Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study, J Bone Miner Res, 17, 1904, 10.1359/jbmr.2002.17.10.1904 · DOI · Paper page
  27. Hale, 2002, Isoflavone supplementation and endothelial function in menopausal women, Clin Endocrinol, 56, 693, 10.1046/j.1365-2265.2002.01533.x · DOI
  28. Alekel, 2000, Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women, Am J Clin Nutr, 72, 844, 10.1093/ajcn/72.3.844 · DOI · Paper page
  29. Han, 2002, Benefits of soy isoflavone therapeutic regimen on menopausal symptoms, Obstet Gynecol, 99, 389
  30. Wiseman, 2000, Isoflavone phytoestrogens consumed in soy decrease F2-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans, Am J Clin Nutr, 72, 395, 10.1093/ajcn/72.2.395 · DOI · Paper page
  31. Simons, 2000, Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women, Am J Cardiol, 85, 1297, 10.1016/S0002-9149(00)00759-1 · DOI
  32. Jenkins, 2000, Effect of soy protein foods on low-density lipoprotein oxidation and ex vivo sex hormone receptor activity: a controlled crossover trial, Metabolism, 49, 537, 10.1016/S0026-0495(00)80022-0 · DOI
  33. Nestel, 1999, Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women, J Clin Endocrinol Metab, 84, 895
  34. Potter, 1998, Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women, Am J Clin Nutr, 68, 1375S, 10.1093/ajcn/68.6.1375S · DOI · Paper page
  35. Duncan, 1999, Soy isoflavones exert modest hormonal effects in premenopausal women, J Clin Endocrinol Metab, 84, 192
  36. Jayagopal, 2002, Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes, Diabetes Care, 25, 1709, 10.2337/diacare.25.10.1709 · DOI · Paper page
  37. Anderson, 2002, Soy isoflavones: no effects on bone mineral content and bone mineral density in healthy, menstruating young adult women after one year, J Am Coll Nutr, 21, 388, 10.1080/07315724.2002.10719240 · DOI
  38. Uesugi, 2002, Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal Japanese women: a four-week study, J Am Coll Nutr, 21, 97, 10.1080/07315724.2002.10719200 · DOI · Paper page
  39. Princen, 1998, No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers, Arterioscler Thromb Vasc Biol, 18, 833, 10.1161/01.ATV.18.5.833 · DOI · Paper page
  40. Gomikawa, 2002, Effects of catechins and ground green tea drinking on the susceptibility of plasma and LDL to the oxidation in vitro and ex vivo, J Clin Biochem Nutr, 32, 55, 10.3164/jcbn.32.55 · DOI
  41. Sung, 2000, In vivo antioxidant effect of green tea, Eur J Clin Nutr, 54, 527, 10.1038/sj.ejcn.1600994 · DOI
  42. Nakagawa, 1999, Tea catechin supplementation increases antioxidant capacity and prevents phospholipid hydroperoxidation in plasma of humans, J Agric Food Chem, 47, 3967, 10.1021/jf981195l · DOI
  43. het Hof, 1999, Plasma and lipoprotein levels of tea catechins following repeated tea consumption, Proc Soc Exp Biol Med, 220, 203
  44. Rumpler, 2001, Oolong tea increases metabolic rate and fat oxidation in men, J Nutr, 131, 2848, 10.1093/jn/131.11.2848 · DOI
  45. Dulloo, 1999, Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans, Am J Clin Nutr, 70, 1040, 10.1093/ajcn/70.6.1040 · DOI · Paper page
  46. Samman, 2001, Green tea or rosemary extract added to foods reduces nonheme-iron absorption, Am J Clin Nutr, 73, 607, 10.1093/ajcn/73.3.607 · DOI
  47. Hodgson, 2002, Regular ingestion of black tea improves brachial artery vasodilator function, Clin Sci, 102, 195, 10.1042/cs1020195 · DOI · Paper page
  48. Hodgson, 2002, Regular ingestion of tea does not inhibit in vivo lipid peroxidation in humans, J Nutr, 132, 55, 10.1093/jn/132.1.55 · DOI
  49. Hodgson, 2000, Acute effects of ingestion of black and green tea on lipoprotein oxidation, Am J Clin Nutr, 71, 1103, 10.1093/ajcn/71.5.1103 · DOI
  50. Chantre, 2002, Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity, Phytomedicine, 9, 3, 10.1078/0944-7113-00078 · DOI · Paper page
  51. Young, 2002, Green tea extract only affects markers of oxidative status postprandially: lasting antioxidant effect of flavonoid-free diet, Br J Nutr, 87, 343, 10.1079/BJN2002523 · DOI
  52. Freese, 1999, Green tea extract decreases plasma malondialdehyde concentration but does not affect other indicators of oxidative stress, nitric oxide production, or hemostatic factors during a high-linoleic acid diet in healthy females, Eur J Nutr, 38, 149, 10.1007/s003940050056 · DOI
  53. het Hof, 1997, Consumption of green or black tea does not increase resistance of low- density lipoprotein to oxidation in humans, Am J Clin Nutr, 66, 1125, 10.1093/ajcn/66.5.1125 · DOI · Paper page
  54. Maxwell, 1996, Tea flavonoids have little short term impact on serum antioxidant activity, Br Med J, 313, 229, 10.1136/bmj.313.7051.229a · DOI
  55. Ishikawa, 1997, Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification, Am J Clin Nutr, 66, 261, 10.1093/ajcn/66.2.261 · DOI · Paper page
  56. Duffy, 2001, Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease, Circulation, 104, 151, 10.1161/01.CIR.104.2.151 · DOI · Paper page
  57. Duffy, 2001, Effect of acute and chronic tea consumption on platelet aggregation in patients with coronary artery disease, Arterioscler Thromb Vasc Biol, 21, 1084, 10.1161/01.ATV.21.6.1084 · DOI
  58. Rein, 2000, Epicatechin in human plasma: in vivo determination and effect of chocolate consumption on plasma oxidation status, J Nutr, 130, 2109S, 10.1093/jn/130.8.2109S · DOI · Paper page
  59. Holt, 2002, Chocolate consumption and platelet function, JAMA, 287, 2212, 10.1001/jama.287.17.2212 · DOI
  60. Pearson, 2002, The effects of flavanol-rich cocoa and aspirin on ex vivo platelet function, Thromb Res, 106, 191, 10.1016/S0049-3848(02)00128-7 · DOI
  61. Wan, 2001, Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans, Am J Clin Nutr, 74, 596, 10.1093/ajcn/74.5.596 · DOI · Paper page
  62. Murphy, 2003, Dietary flavanols and procyanidin oligomers from cocoa ( Theobroma cacao ) inhibit platelet function, Am J Clin Nutr, 77, 1466, 10.1093/ajcn/77.6.1466 · DOI · Paper page
  63. Taubert, 2003, Chocolate and blood pressure in elderly individuals with isolated systolic hypertension, JAMA, 290, 1029, 10.1001/jama.290.8.1029 · DOI · Paper page
  64. Wang, 2000, A dose-response effect from chocolate consumption on plasma epicatechin and oxidative damage, J Nutr, 130, 2115S, 10.1093/jn/130.8.2115S · DOI · Paper page
  65. Ni, 2002, Treatment of melasma with Pycnogenol, Phytother Res, 16, 567, 10.1002/ptr.1085 · DOI
  66. Devaraj, 2002, Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profile, Lipids, 37, 931, 10.1007/s11745-006-0982-3 · DOI · Paper page
  67. Hosseini, 2001, A randomized, double-blind, placebo-controlled, prospective, 16-week crossover study to determine the role of Pycnogenol in modifying blood pressure in mildly hypertensive patients, Nutr Res, 21, 1251, 10.1016/S0271-5317(01)00342-6 · DOI
  68. Stefanescu, 2001, Pycnogenol efficacy in the treatment of systemic lupus erythematosus patients, Phytother Res, 15, 698, 10.1002/ptr.915 · doi:10.1002/ptr.915
  69. Arcangeli, 2000, Pycnogenol in chronic venous insufficiency, Fitoterapia, 71, 236, 10.1016/S0367-326X(99)00164-1 · DOI
  70. Putter, 1999, Inhibition of smoking-induced platelet aggregation by aspirin and Pycnogenol, Thromb Res, 95, 155, 10.1016/S0049-3848(99)00030-4 · DOI
  71. Wang, 1999, The effect of Pycnogenol on the microcirculation, platelet function and ischemic myocardium in patients with coronary artery diseases, Eur Bull Drug Res, 7, 19
  72. Araghi-Niknam, 1999, Pine bark extract reduces platelet aggregation, Integr Med, 2, 73, 10.1016/S1096-2190(00)00002-0 · DOI
  73. Pavlovic, 1999, Improved endurance by use of antioxidants, Eur Bull Drug Res, 7, 26
  74. Roseff, 2002, Improvement in sperm quality and function with French maritime pine tree bark extract, J Reprod Med, 47, 821
  75. Saliou, 2001, Solar ultraviolet-induced erythema in human skin and nuclear factor-κB–dependent gene expression in keratinocytes are modulated by a French maritime pine bark extract, Free Radic Biol Med, 30, 154, 10.1016/S0891-5849(00)00445-7 · DOI
  76. Kohama, 1999, The treatment of gynaecological disorders with Pycnogenol, Eur Bull Drug Res, 7, 30
  77. Kontiokari, 2001, Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women, Br Med J, 322, 1571, 10.1136/bmj.322.7302.1571 · DOI · Paper page
  78. Campbell, 2003, A randomised trial of cranberry versus apple juice in the management of urinary symptoms during external beam radiation therapy for prostate cancer, Clin Oncol, 15, 322, 10.1016/S0936-6555(03)00161-4 · doi:10.1016/s0936-6555(03)00161-4
  79. Young, 1999, Effect of fruit juice intake on urinary quercetin excretion and biomarkers of antioxidative status, Am J Clin Nutr, 69, 87, 10.1093/ajcn/69.1.87 · DOI · Paper page
  80. Watzl, 2002, Acute intake of moderate amounts of red wine or alcohol has no effect on the immune system of healthy men, Eur J Nutr, 41, 264, 10.1007/s00394-002-0384-0 · DOI · Paper page
  81. Nigdikar, 1998, Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo, Am J Clin Nutr, 68, 258, 10.1093/ajcn/68.2.258 · DOI · Paper page
  82. van der Gaag, 2000, Effect of consumption of red wine, spirits, and beer on serum homocysteine, Lancet, 355, 1522, 10.1016/S0140-6736(00)02172-3 · DOI · Paper page
  83. Cuevas, 2000, A high-fat diet induces and red wine counteracts endothelial dysfunction in human volunteers, Lipids, 35, 143, 10.1007/BF02664763 · DOI · Paper page
  84. Freedman, 2001, Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release, Circulation, 103, 2792, 10.1161/01.CIR.103.23.2792 · DOI · Paper page
  85. Chou, 2001, Effect of ingestion of purple grape juice on endothelial function in patients with coronary heart disease, Am J Cardiol, 88, 553, 10.1016/S0002-9149(01)01738-6 · DOI
  86. Keevil, 2000, Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation, J Nutr, 130, 53, 10.1093/jn/130.1.53 · DOI · Paper page
  87. Vigna, 2003, Effect of a standardized grape seed extract on low-density lipoprotein susceptibility to oxidation in heavy smokers, Metabolism, 52, 1250, 10.1016/S0026-0495(03)00192-6 · DOI
  88. Preuss, 2000, Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: a pilot study, J Med, 31, 227
  89. Stein, 1999, Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease, Circulation, 100, 1050, 10.1161/01.CIR.100.10.1050 · DOI · Paper page
  90. Aviram, 2002, Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans, Drugs Exp Clin Res, 28, 49
  91. Aviram, 2000, Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice, Am J Clin Nutr, 71, 1062, 10.1093/ajcn/71.5.1062 · DOI · Paper page
  92. Dartenuc, 1980, Résistance capillaire en gériatrie etude d’un microangioprotecteur: endotélon. (Hair resistance in geriatrics studied with a microangioprotector: endothelon.), Bordeaux Med, 13, 903
  93. Corbé, 1998, Sens lumineux et circulation choriorétinienne: etude de l’effet des O.P.C. (Endotélon). (Luminosity and chorioretic circulation: a study on the effects of O.P.C. (endothelon).), J Fr Ophthalmol, 11, 453
  94. Lagrue, 1981, A study of the effects of procyanidin oligomers on capillary resistance in hypertension and in certain nephropathies, Sem Hop, 57, 1399
  95. Day, 2001, Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin, Free Radic Res, 212, 941, 10.1080/10715760100301441 · DOI · Paper page
  96. DuPont, 2000, Effect of variety, processing, and storage on the flavonoid glycoside content and composition of lettuce and endive, J Agric Food Chem, 48, 3957, 10.1021/jf0002387 · DOI · Paper page
  97. Day, 2000, Conjugation position of quercetin glucuronides and effect on biological activity, Free Radic Biol Med, 29, 1234, 10.1016/S0891-5849(00)00416-0 · DOI · Paper page
  98. Cano, 2002, Superoxide scavenging by polyphenols: effect of conjugation and dimerization, Redox Rep, 7, 379, 10.1179/135100002125001153 · DOI
  99. O’Leary, 2003, Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human β-glucuronidase, sulfotransferase, catechol- O -methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism, Biochem Pharmacol, 65, 479, 10.1016/S0006-2952(02)01510-1 · DOI · Paper page
  100. Shimoi, 2001, Deglucuronidation of a flavonoid, luteolin monoglucuronide, during inflammation, Drug Metab Dispos, 29, 1521
  101. Setchell, 1999, Dietary isoflavones: biological effects and relevance to human health, J Nutr, 129, 758S, 10.1093/jn/129.3.758S · DOI · Paper page
  102. Setchell, 2002, The clinical importance of the metabolite equol: a clue to the effectiveness of soy and its isoflavones, J Nutr, 132, 3577, 10.1093/jn/132.12.3577 · DOI · Paper page
  103. Kishida, 2000, Soybean meal fermented by Aspergillus awamori increases the cytochrome P-450 content of the liver microsomes of mice, J Agric Food Chem, 48, 1367, 10.1021/jf9905830 · doi:10.1021/jf9905830
  104. Izumi, 2000, Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans, J Nutr, 130, 1695, 10.1093/jn/130.7.1695 · DOI · Paper page
  105. Zhang, 1999, Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells at nutritionally relevant concentrations, J Nutr, 129, 399, 10.1093/jn/129.2.399 · DOI · Paper page
  106. Lee, 2002, Pharmacokinetics of tea catechins after ingestion of green tea and (−)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability, Cancer Epidemiol Biomarkers Prev, 11, 1025
  107. Holt, 2002, Procyanidin dimer B2 [epicatechin-(4β-8)-epicatechin] in human plasma after the consumption of a flavanol-rich cocoa, Am J Clin Nutr, 76, 798, 10.1093/ajcn/76.4.798 · DOI · Paper page
  108. Yang, 1998, Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers, Cancer Epidemiol Biomarkers Prev, 7, 351
  109. Bell, 2000, (+)-Catechin in human plasma after ingestion of a single serving of reconstituted red wine, Am J Clin Nutr, 71, 103, 10.1093/ajcn/71.1.103 · DOI · Paper page
  110. Pascual-Teresa, 2000, Quantitative analysis of flavan-3-ols in Spanish foodstuffs and beverages, J Agric Food Chem, 48, 5331, 10.1021/jf000549h · DOI · Paper page
  111. Sano, 2003, Procyanidin B1 is detected in human serum after intake of proanthocyanidin-rich grape seed extract, Biosci Biotechnol Biochem, 67, 1140, 10.1271/bbb.67.1140 · DOI · Paper page
  112. Donovan, 2002, Procyanidins are not bioavailable in rats fed a single meal containing a grapeseed extract or the procyanidin dimer B-3, Br J Nutr, 87, 299, 10.1079/BJN2001517 · DOI · Paper page
  113. Rios, 2003, Chocolate intake increases urinary excretion of polyphenol-derived phenolic acids in healthy human subjects, Am J Clin Nutr, 77, 912, 10.1093/ajcn/77.4.912 · DOI · Paper page

Cited by

See all 1,340

Metadata

Authors
Williamson, G., & Manach, C.
Venue
The American Journal of Clinical Nutrition
Publisher
Elsevier BV
Published
2005-01
Volume
81
Issue
1
Pages
243S-255S
ISSN
0002-9165 (ISSN-L)
OpenAlex
W2144618543
Cited by
1,340
References
7
FWCI
35.99
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. https://app.cochat.ai/papers/10.1093/ajcn/81.1.243s
The paper
Williamson, G., & Manach, C. (2005). Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. The American Journal of Clinical Nutrition. https://doi.org/10.1093/ajcn/81.1.243s

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.